ARVO 2024: 12-month results of a mutation agnostic optogenetic program for patients with severe vision loss from RP Martin David Harp;David Hutton May 11th 2024 At this year's ARVO meeting, Allen Ho, MD, presented a paper on the 12-month results of a mutation agnostic optogenetic program fo...
Hello, I'm Dr. Allen Ho from Wills Eye Hospital and Mid Atlantic Retina. And today at the ARVO 2024 meeting, I'm presenting a paper on the 12-month results of a mutation agnostic optogenetic program for patients with severe vision loss from retinitis pigmen...
Download the program for ARVO 2024. Easily access event sessions, speakers, exhibitors, and organizer messages. Download the native app to personalize your sche…
Dr. Sicks notes the mechanism connecting BMI to dry eye is unclear at this time. “There are a lot of other facets to dry eye,” she explains. “In a separate analysis of this cohort (forthcoming OVS publication, Fall 2024), we found evidence that BMI is correlated to meibomian gland m...
Session Date/Time: May 9, 2024 from 8:00 AM to 9:45 AM About AAVantgarde Bio AAVantgarde Bio is a clinical stage, Italian headquartered, international biotechnology company that has developed two proprietary Adeno-Associated Viral (AAV) v...
Hi, I'm Carl Danzig and I'm happy to be here at ARVO. I'm happy to talk about the post hoc analysis regarding vision loss in the GATHER program. This is exciting new data that I'm presenting, and what we saw in the GATHER – in this analysis regarding the GATHER program was...
In the event that scientists are unable to attend ARVO 2023, the dates for ARVO 2024 are May 5-9 in Seattle.
The poster presentation from AAVantgarde’s Stargardt program will report preliminary data from the NHP GLP study, designed to evaluate the safety and pharmacokinetics of subretinal administration of dual AAV8.A...
编者按:ARVO 2024正在如火如荼开展,会议呈现出青光眼相关的多个方面的进展,包括早期诊断、疫情期间手术量的变化、药物治疗策略以及联合手术的长期效果观察等。这些研究成果为青光眼的临床管理和治疗提供了新的视角和思路。随着研究的不断深入,人们对青光眼的认识和治疗手段也在不断演进,为患者提供更加全面和个性化的医疗服...
Nov 16, 2024 index.html 5.11.5 Nov 5, 2024 mix.exs 5.11.15 Nov 15, 2024 Repository files navigation README License SYNRC 🛡️ CA Features PKI entities: CA, RA, SERVER, CLIENT, HUMAN, PROGRAM Key purposes: TLS, ECDSA, AES, SSH, SCVP, IPSEC, CMC, SIP, CAP, EAP, BGP, OCSP EU...